Sector consensus Gan & Lee Pharmaceuticals.

Equities

End-of-day quote Shanghai S.E. Other stock markets 06/03/2026			5-day change	1st Jan Change
63.66 ^CNY	+2.53%		-3.25%	-6.48%

03-03	Gan & Lee Pharmaceuticals Gets Regulatory Nod for Prostate Cancer Drug Trials	MT
01-22	Gan & Lee Pharmaceuticals Expects 2025 Profit to Jump Up to 95%	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
GAN & LEE PHARMACEUTICALS.			CN¥79.5	+28.04%	2
REGENERON PHARMACEUTICALS, INC.			US$872.67	+14.08%	27
UCB			€284.6	+10.35%	20
SAMSUNG BIOLOGICS CO.,LTD.			₩2,253,934.38	+36.85%	25
CSL LIMITED			A$149.08	+45.7%	16
BIOGEN INC.			US$205.67	+9.35%	30
MODERNA, INC.			US$42.9	-20.3%	20
INCYTE CORPORATION			US$108.77	+11.76%	22
INNOVENT BIOLOGICS, INC.			HK$102.34	+48.16%	26
SWEDISH ORPHAN BIOVITRUM AB			SEK 423.6	+11.12%	10
ALTEOGEN INC.			₩435,000	+16.94%	4
BRIDGEBIO PHARMA, INC.			US$100.05	+51.2%	21
BIOMARIN PHARMACEUTICAL INC.			US$89.48	+47.73%	23
AXSOME THERAPEUTICS, INC.			US$222.47	+37.78%	21
KRYSTAL BIOTECH, INC.			US$313.22	+20.32%	9
GRIFOLS, S.A.			€15.3	+46.93%	12
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-	-	CN¥50	+31.48%	1
3SBIO INC.			HK$34.72	+99.48%	11
SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.	-	-	-	-	-
Average			149,557.15	+30.39%	17
Weighted average by Cap.			292,723.27	+24.39%	21